Prime Minister Benjamin Netanyahu announced Friday that he underwent treatment for a malignant prostate tumor after previously undergoing surgery for benign prostate enlargement. At a routine check-up following his prostate surgery in December 2024,

Prostate cancer has long frustrated immunologists. Checkpoint inhibitors that unleash the immune system against tumors in the skin, lung, and bladder have largely fallen short in the prostate, in part because immune cells circulating in the blood struggle to infiltrate the gland’s dense tissue.